Radiopharmaceutical Services

The Vendor is required to provide radiopharmaceutical products provided will be for utilization within the hospital, clinics, and research and satellite facilities for the department.
- Requirement:
•    Availability to dispense and deliver diagnostic and therapeutic radiopharmaceuticals twenty-four (24) hours, seven (7) days a week. 
•    Capability to dispense and deliver the following:
o    Unit dose [syringe or vial]
o    Bulk activity
o    Custom iodine capsules (i-123 and i – 131)
o    Custom iodine liquid (i-131)
o    Calibration point sources
o    Pharmaceutical kits
o    Blood product labeling
o    Sheet sources
o    Y-90 microsphere therapy custom patient unit dose
o    Other diagnostic and therapy custom patient unit and bulk dose
o    Supplies and accessories
•    Strong communication skills – supplier will utilize the best modes of communication with agency to ensure timely notification of radiopharmaceutical delays, shortages, or process changes that will affect operational practices. 
•    Utilizes returned dose program – supplier must provide agency a copy of their return merchandize authorization program and educate agency accordingly. 
•    Program must address applicable unused unit dose activity returned for credit and have the ability to customize based upon agency needs. 
•    Utilizes regulatory radioactive waste program – provide retrieval and decay of all radioactive waste from activity delivered per dot standards. 
•    Utilizes quality control (QC) – assure that all QC measures have been completed upon delivery of dose and provide documentation for QC results upon request. 
•    All required regulatory and quality standards assurance for radiopharmaceuticals and pharmaceuticals are upheld until expiration date and time. 
•    Utilizes single point of billing – for all radiopharmaceutical and pharmaceuticals prepared for patient administration, invoices will be customizable to meet the need of the entire operation and not solely based on ship-to location. 
•    Utilizes safety net of backup suppliers - to limit the impact on clinical operations during times of disruption in radiopharmaceutical production by the vendor.